Table 2.
Clinical, anthropometric, and biochemical features of T2DM patients before and after the COVID lockdown.
| N° | Before lockdown |
After lockdown |
||||
|---|---|---|---|---|---|---|
| Mean ± SD | Median (IQR) | Mean ± SD | Median (IQR) | P | ||
| BMI, kg/m2 | 303 | 29.2 ± 5 | 28.8 (25.7–32.4) | 29.3 ± 5.2 | 28.7 (25.5–32.7) | 0.032§ |
| Weight, kg | 303 | 81.5 ± 15.9 | 82 (71–91) | 81.8 ± 16.3 | 82 (70–92) | 0.023§ |
| WC, cm | 244 | 104.4 ± 12.4 | 103 (97–113) | 105 ± 13.9 | 104 (97–114) | 0.001§ |
| HbA1c, % | 304 | 7.1 ± 0.9 | 7 (6.4–7.6) | 7.1 ± 0.9 | 7 (6.4–7.6) | 0.600* |
| HbA1c, mmol/mol | 304 | 53.7 ± 10.1 | 53 (47–60) | 54.7 ± 10.4 | 52.5 (47–59.7) | 0.931* |
| FPG, mmol/l | 301 | 8.6 ± 2.1 | 8.3 (7.1–9.8) | 8.8 ± 2.5 | 8.4 (7.3–9.7) | 0.353* |
| Creatinine, mg/dl | 301 | 1 ± 0.36 | 0.92 (0.77–1.14) | 1.1 ± 0.6 | 0.96 (0.79–1.23) | 0.003§ |
| eGFR, ml/min/1.73 m2 | 301 | 79 ± 23.9 | 80 (61–95) | 76 ± 25.8 | 75 (58–94) | 0.001* |
| TC, mmol/l | 297 | 4.2 ± 0.8 | 4.2 (3.6–4.6) | 4.0 ± 0.8 | 3.9 (3.4–4.5) | 0.021* |
| HDL, mmol/l | 297 | 1.3 ± 0.3 | 1.2 (1.0–1.4) | 1.2 ± 0.3 | 1.2 (1.0–1.4) | 0.008§ |
| LDL, mmol/l | 295 | 2.2 ± 0.7 | 2.1 (1.7–2.6) | 2.1 ± 0.7 | 2.0 (1.5–2.5) | 0.006§ |
| TG, mmol/l | 244 | 1.5 ± 0.9 | 1.3 (1.0–1.8) | 1.6 ± 0.9 | 1.3 (1.0–1.9) | 0.379§ |
Abbreviations: BMI, body mass index; WC, waist circumference; HbA1c, glycated haemoglobin; eGFR, estimated glomerular filtration rate; TC, total-cholesterol; HDL, high density lipoprotein cholesterol; LDL, low density lipoprotein cholesterol, TG, triglycerides.
*
Student’s t-test.
§
Wilcoxon Rank test.